USPH Stock Price | U.S. Physical Therapy, Inc. P/E, Revenue, EPS, & Forecasts

U.S. Physical Therapy, Inc. • USPH

Capital at risk.

About
Metrics
Forecasts
Earnings performance
Financial performance
Sentiment analysis
FAQs

Calendar

event

Ex dividend date

22 May 2026

calendar_clock

Next Dividend Payment

12 Jun 2026

About U.S. Physical Therapy, Inc.

Ticker

USPH

Trading on

NYSE

ISIN

US90337L1089

Industry

Medical Care Facilities

Sector

Healthcare

CEO

Christopher J. Reading

Headquarters

1300 West Sam Houston Parkway South, Houston, TX, United States, 77042

Employees

4,653

Website

usph.com

U.S. Physical Therapy, Inc., together with its subsidiaries, operates and manages outpatient physical therapy clinics. It operates through two segments, Physical Therapy Operations and Industrial Injury Prevention Services. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. It offers industrial injury prevention services, including onsite injury prevention and rehabilitation, performance optimization, post-offer employment testing, functional capacity evaluations, and ergonomic assessments through physical therapists and specialized certified athletic trainers for Fortune 500 companies, and other clients comprising insurers and their contractors. U.S. Physical Therapy, Inc. was founded in 1990 and is based in Houston, Texas.

Metrics

BasicAdvanced

Market cap

$966M

P/E ratio

126.9

EPS

$0.50

Dividend Yield

2.93%

Beta

1.16

Forward P/E ratio

23.09

EBIDTA

$103M

Ex dividend date

2026-05-22

Price & volume

Market cap

$966M

Average daily volume

0.3M

90-day return

30-day return

7-day return

Dividends

Dividend per share

$1.81

Dividend yield

2.93%

Forward dividend per share

$1.82

Forward dividend yield

2.87%

Payout ratio

70.00%

Valuation

P/E ratio

126.9

Forward P/E

23.09

PEG ratio

2.31

Trailing P/E

126.9

Price to sales

1.23

Price to book

2.06

Earnings

EPS

$0.50

EPS estimate (current quarter)

$0.52

EPS estimate (next quarter)

$0.81

EBITDA

$103M

Revenues (TTM)

$788M

Revenues per share (TTM)

$51.88

Technicals

Beta

1.16

52-week High

$91.69

52-week Low

$57.76

50-day moving average

$69.92

200-day moving average

$79.03

Short ratio

3.97

Short %

7.28%

Management effectiveness

ROE (TTM)

6.84%

ROA (TTM)

4.13%

Profit margin

4.41%

Gross profit margin

$173M

Operating margin

7.34%

Growth

Quarterly earnings growth (YoY)

23.60%

Quarterly revenue growth (YoY)

7.90%

Share stats

Outstanding Shares

15.2M

Float

14.8M

Insiders %

2.47%

Institutions %

108.38%

Analyst Insights & forecasts

86% Buy

14% Hold

0% Sell

Based on information from 7 analysts.

Average price target

$93.67

Earnings per share (EPS) forecast

windowbar_chart_4_bars

Actual

Expected

Surprise

$0.81

$0.69

17.39%

Q2 • 25Beat

$0.66

Q3 • 25Beat

$0.67

-0.56%

Q4 • 25Missed

$0.46

$0.52

-11.54%

Q1 • 26Current

QuarterlyAnnual

Financial Performance

windowbar_chart_4_bars

Income StatementBalance SheetCash Flow

windowbar_chart_4_bars

Revenue

Net income

Profit margin

$203M

$-10.5M

-5.20%

Q4 • 25

$198M

$-4.3M

-2.18%

Q1 • 26

-2.19%

-58.94%

-58.02%

QoQ growth

QuarterlyAnnual

Totals assets

Total liabilities

Debt to assets

$1.2B

$434M

36.03%

Q4 • 25

$1.24B

$459M

36.97%

Q1 • 26

3.16%

5.85%

2.61%

QoQ growth

QuarterlyAnnual

Operating

Investing

Financing

Free cash flow

$24.9M

$-15M

$21M

Q4 • 25

$4M

$28.9M

$-1.4M

Q1 • 26

-83.94%

-292.16%

-106.52%

QoQ growth

QuarterlyAnnual

Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Past performance is no guarantee of future results. Your return may be affected by currency fluctuations and applicable fees and charges. The value of your investment may go up as well as down. When investing, your capital at risk.

Build your future fund today!

Automate your wealth-building journey and turn investing into a habit that your future self will be grateful for!

Capital at risk.

FAQs

How much is a U.S. Physical Therapy, Inc. share?

U.S. Physical Therapy, Inc. shares are currently traded for undefined per share.

How many shares does U.S. Physical Therapy, Inc. have?

U.S. Physical Therapy, Inc. currently has 15.2M shares.

Does U.S. Physical Therapy, Inc. pay dividends?

Yes, U.S. Physical Therapy, Inc. does pay dividends.

What is U.S. Physical Therapy, Inc. 52 week high?

U.S. Physical Therapy, Inc. 52 week high is $91.69.

What is U.S. Physical Therapy, Inc. 52 week low?

U.S. Physical Therapy, Inc. 52 week low is $57.76.

What is the 200-day moving average of U.S. Physical Therapy, Inc.?

U.S. Physical Therapy, Inc. 200-day moving average is $79.03.

Who is U.S. Physical Therapy, Inc. CEO?

The CEO of U.S. Physical Therapy, Inc. is Christopher J. Reading.

How many employees U.S. Physical Therapy, Inc. has?

U.S. Physical Therapy, Inc. has 4,653 employees.

What is the market cap of U.S. Physical Therapy, Inc.?

The market cap of U.S. Physical Therapy, Inc. is $966M.

What is the P/E of U.S. Physical Therapy, Inc.?

The current P/E of U.S. Physical Therapy, Inc. is 126.9.

What is the EPS of U.S. Physical Therapy, Inc.?

The EPS of U.S. Physical Therapy, Inc. is $0.50.

What is the PEG Ratio of U.S. Physical Therapy, Inc.?

The PEG Ratio of U.S. Physical Therapy, Inc. is 2.31.

What do analysts say about U.S. Physical Therapy, Inc.?

According to the analysts U.S. Physical Therapy, Inc. is considered a buy.